Physician profile
Ashley Rode
NPI 1841722543
$1,823.60
in general payments reported to CMS, 2019-2025
19 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $246 · 2023: $1,078 · 2024: $377 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,335 · Education: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.76 |
| Education | $242.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $429.76 | 2022-2024 | |
| Astellas Pharma US INC | $326.01 | 2023-2024 | Veozah, Myrbetriq |
| Novo Nordisk INC | $261.46 | 2023-2024 | Wegovy |
| Abbvie INC. | $208.48 | 2022-2023 | |
| Lilly USA, LLC | $122.67 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.50 | 2022 | |
| Evofem Biosciences, INC. | $66.60 | 2022-2023 | Phexxi |
| Exact Sciences Corporation | $54.19 | 2023 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $43.68 | 2022-2023 | Contrave |
| Organon LLC | $35.02 | 2022-2023 | Nexplanon |
| Axonics, INC. | $32.99 | 2023 | Axonics |
| Amgen INC. | $25.99 | 2023 | Prolia, Evenity |
| Coloplast Corp | $24.35 | 2023 | Altis |
| Mylan Pharmaceuticals INC. | $24.16 | 2022 | |
| Exeltis, USA INC. | $22.69 | 2023 | Slynd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $21.28 | 2022 | |
| Sumitomo Pharma America, INC. | $20.44 | 2023 | Gemtesa |
| Agile Therapeutics, INC. | $19.42 | 2023 | Twirla |
| Aspira Women'S Health INC | $16.91 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Rode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.